π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The goal of this randomized clinical trial is to learn if topical treatment...
Status
Recruiting
Location
Genesis Cancer and Blood Institute
Start Date
2025-08-25
Trial ID
NCT06830863
Hand-Foot Skin Reaction (HFSR) is a common adverse event induced by Vascula...
Status
Unknown
Location
Western Regional Medical Center
Start Date
2019-12-09
Trial ID
NCT04088318
Treatments Being Tested
Epidermolysis bullosa simplex (EBS) is a rare genetic skin disease characte...
Status
Terminated
Location
Phoenix Childrens Hospital
Start Date
2017-06-01
Trial ID
NCT03154333
Treatments Being Tested
This study is being conducted to characterize the mechanism of action of cr...
Status
Completed
Location
Innovaderm Research Incorporated
Start Date
2017-07-31
Trial ID
NCT03233529
Treatments Being Tested
This Phase III study is designed to evaluate the efficacy and safety of KX2...
Status
Completed
Location
Coastal Clinical Research, Inc.
Start Date
2017-09-18
Trial ID
NCT03285477
Treatments Being Tested
A Phase 2, randomized, double-blind, dose rising study to determine the saf...
Status
Completed
Location
Moore Clinical Research
Start Date
2017-05-18
Trial ID
NCT03083470
Treatments Being Tested
The study is beng done to test if tofacitinib ointment is safe and effectiv...
Status
Completed
Location
Burke Pharmaceutical Research
Start Date
2013-05
Trial ID
NCT01831466
Randomized, Vehicle-controlled, Parallel Group Study of TDM-180935 in Atopi...
Status
Completed
Location
Site 5
Start Date
2024-04-13
Trial ID
NCT06363461
The purpose of this study is to evaluate the efficacy and safety of two dos...
Status
Completed
Location
Clinical Research Site
Start Date
2004-09
Trial ID
NCT00373516
The purpose of this study is to determine the safety and efficacy of three ...
Status
Completed
Location
PAREXEL International (Bloemfontein)
Start Date
2009-07-15
Trial ID
NCT00944632
Treatments Being Tested